
ã³ããã«ããããã¯ããŠã³:èš±ããŠã¯ãªãããå¿ããŠã¯ãªããªã
å èšäºã¯ãã¡ããã/Click here to read the original article.
ã³ããçŠã®ããã³ãããã¯ãäžã«å®æœãããããã¯ããŠã³æ¿çã¯å£æ»
çãªãã®ã§ããããããã®æ¿çã¯ãã®æå¹æ§ã«ã€ããŠæ€èšŒãããã¹ãã§ãããããããããã«å¯Ÿããé¢å¿ã¯ã»ãšãã©ç€ºãããŠããŸããã
以äžã§ã¯ãã€ã¢ã³ã»ãã©ãŒãã¹ãŠã§ãŒãã³ã®è»œææ®µçãªã¢ãããŒããšä»ã®æ¬§å·æ¿åºã®åŒ·ç¡¬ãªã¢ãããŒããæ¯èŒããç ç©¶ã玹ä»ããŸãã
ãããã¯ããã¯ããŠã³ã¢ãã«ã®æç¢ºãªåŠå®ã ããšåœŒã¯æžããŠããããã ããããã仿¥ã¹ãŠã§ãŒãã³ã®äŸãæå³çã«ç¡èŠãããŠããã®ã§ããã
ããã¯ããŠã³ã®æšäºã¯èš±ãããŠã¯ãªããªã:å€§èŠæš¡ãªæ¬§å·èª¿æ»ãã¹ãŠã§ãŒãã³ã®åžžèçãªãã³ãããã¯å¯Ÿå¿ãæ£åœå
ã€ã¢ã³ã»ãã©ãŒèããã©ãŠã³ã¹ããŒã³ç ç©¶æããåºç
ç§ãã¡ã¯ä»ãã15æ¥éã§ã¹ããŒã»ã¶ã»ã¹ãã¬ãããã®6åšå¹Žãæ¥éã«è¿ããããšããŠããŸãã
ãã®æ¿çã¯äžçå²äžæãæ²æšãªãã®ã®äžã€ã§ããããã³ãããã¯åã®èšç»ææžããã¹ãŠæåã®æ©äŒã«æãæšãŠããå°éå®¶ãã«ãã£ãŠäœãããŸããã
ããã¯äžåœããã®äžæ£ç¢ºãªå ±åã«åºã¥ããŠãããäžåœã®ããã¯ããŠã³ã«ãã£ãŠæ°æ¥ã§æ°åã³ãããŠã€ã«ã¹ã®æææ¡å€§ã广çã«æ ¹çµ¶ããããšäž»åŒµãããŠããŸããã
ãã®æ¿çã¯ããžã§ã€ã»ãã¿ãã£ãªã€å士ã®ãããªèåãªç«åŠè ã«ãã確ããªç ç©¶ãç¡èŠãããã®ã§ãã³ãããŠã€ã«ã¹ã¯ãã§ã«ãããŸã§èããããŠãããããã¯ããã«åºç¯å²ã«åºãã£ãŠããããšã瀺ããŠããŸããã
ããã¯ããŠã³ãšããã«äŒŽããã¹ã¯ççšçŸ©åãã¯ã¯ãã³ãã¹ããŒããåŠæ ¡ééãäžéšã®å°åã§æ°å¹Žéç¶ããããšã¯æ°žé ã«ææããŠããã¹ãã§ãããã®å¿ãŸãããæ¿çã®åœ±é¿ã¯æåéãç¡é倧ã«ãªãã§ããããããã¯ããŠã³ãç§ãã¡ã®æ¿çã察å¿ãæåéãäžçã®æŽå²ã®æµããå€ãããšèšã£ãŠãéèšã§ã¯ãããŸããã
ããããæ¿çã广çãã©ãããææ¡ããããã®çµç¹çãªåªåã確ãã«è¡ãããã¯ãã ãåŒåžåšãŠã€ã«ã¹ã«å¯ŸããŠãäŒæ¥ãåŠæ ¡ã«å¯Ÿããæš©åšäž»çŸ©çãªåãç· ãŸããåœãæãããã«å¿ èŠã ã£ããã©ããã¯äžæã§ãã
ããã6幎çµã£ãä»ãæ®å¿µãªãããããã®åé¡ãæ€èšŒããé¢å¿ã¯ã»ãšãã©ãããŸããããããŠã¹ãŠã§ãŒãã³ã®ããŒã¿ãçè§£ãããšããã®çç±ãã¯ã£ãããšãããã§ãããã
ã¹ãŠã§ãŒãã³ã®ã³ãã察çã«é¢ããç ç©¶ã¯ããã¯ããŠã³ã广ã瀺ããªãã£ã
PubMedã«æ²èŒãããç ç©¶ã§ã¯ãã¹ãŠã§ãŒãã³ã®COVIDæ¿çã®ã¢ãããŒãããšãŒããã諞åœãšæ¯èŒããŠæ€èšŒããŸãããäž»ãªçç±ã¯ãã¹ãŠã§ãŒãã³ããã³ãããã¯å¯Ÿå¿ãšããŠããã¯ããŠã³ã«é Œããããèªäž»çãã€æç¶å¯èœãªç·©åå§åããçšããŠããããã§ãã
ãã¹ãŠã§ãŒãã³äººã®å€§å€æ°ãããããã®æ¿çãæ¯æããŠããã«ãããããããããã®ã¢ãããŒãã¯è¿ éãã€ç¶ç¶çãªæ¹å€ã«çŽé¢ããããšè¿°ã¹ãŠããŸãã
ãã®æ¹å€ã¯äž»ã«ãé©ãããšã«ã¢ã³ãœããŒã»ãã¡ãŠãå士ã®ãããªå ¬è¡è¡çé¢ä¿è ããæ¥ãŠããã圌ã¯ã¹ãŠã§ãŒãã³ã矀è¡ã«éãã£ãŠãããšç¹°ãè¿ãæ¹å€ããŸããã
ãããªãã¯ç§ãã¡ãã¹ãŠã§ãŒãã³ãšæ¯èŒããŠããŸãããå€ãã®éãããããŸãããšåœŒã¯2020幎9æã®äžé¢å§å¡äŒå ¬èŽäŒã§èªããŸããããããããã¹ãŠã§ãŒãã³ã®æ»äº¡çãä»ã®åçã®ã¹ã«ã³ãžããã¢è«žåœãšæ¯èŒããŠã¿ãŠãã ããããã£ãšã²ã©ããã ãããã¹ãŠã§ãŒãã³ãæã ãšæ¯èŒããã®ã¯é©åã§ã¯ãªããšæããã
ãã¹ãŠã§ãŒãã³ãèŠããšã圌ãã¯ããªãå°ã£ãŠããããšãã¡ãŠãã¯2020幎æ«ã®ãã°ããã¢ãŒãã³ã°ã»ã¢ã¡ãªã«ãã§èªã£ããã圌ãã¯ãã«ãŠã§ãŒããã³ããŒã¯ããã£ã³ã©ã³ããšãã£ãåšèŸºè«žåœãããæ»äº¡çãã¯ããã«é«ãããšã«æ°ã¥ãå§ããŠããŸã...圌ãã¯ä»ãèªåãã¡ããã£ãããšã®ããã€ããèŠçŽããªããã°ãªããªãããšã«æ°ã¥ãå§ããŠãããã
ãã¡ãããããã¯äºå®ã§ã¯ãããŸããã§ããã圌ãã¯ããã¯ããŠã³ã«å¯Ÿãã軜ãæèšã®æŠç¥ããåèãããŸããã§ããããããŠãã¹ãŠã§ãŒãã³ãé£åœãšã ãæ¯èŒããã®ã¯ãä»ã®ã©ã®åœãåããŠããªãã°ããã誀èªå°ã§ãããããããã¡ãŠãã¯æããã«èª å®ããç¥çèª å®ããéèŠããã¿ã€ãã§ã¯ãªããã¹ãŠã§ãŒãã³ã®å€±æãæãå€ãã®å ¬è¡è¡çé¢ä¿è ã®ä»£çãåããã
ãããããã®ç ç©¶ã瀺ãããã«ãçŸå®ã¯ãŸã£ããéã§ããã
ãã®èª¿æ»ã¯ãã¹ãŠã§ãŒãã³ããå ¬å ±ã®å Žã§ãã¹ã¯ççšãæ³çã«åŒ·å¶ããŠããªããããšãåŠæ ¡ãéãç¶ããŠããããšããããŠæ¿çããå¯å®¹ãããããšæ¹å€ãåããããšã説æããŠããŸããã³ãããæ¢ãåœãæãããã«å¿ èŠã ãšèšããããã¹ãŠã®ããšã§ããç ç©¶è ãã¡ã¯ãããã®äž»åŒµãéå°æ»äº¡çããŒã¿ãšå³æ Œæ§ææ°ãçšããŠãé£åœã ãã§ãªããšãŒãããå šäœã®ã¹ãŠã§ãŒãã³ãæ¯èŒããŸããã
圌ããéžãã ã®ã¯ãã³ããç¹æã®æž¬å®ãšã¯ç°ãªããåããæ€æ»ã»ã«ãŠã³ãã®éããå人ã«ããã³ããé¢é£ã®çµæã®å®çŸ©ã®åœ±é¿ãå°ãªãããã§ãããŸããã峿 Œãªããã¯ããŠã³æªçœ®ã®æªåœ±é¿ãå»çã·ã¹ãã å šäœã®è² æ ãä»ã®ç æ°ã®å»çã¢ã¯ã»ã¹ã®æžå°ãªã©ã鿥çã«èµ·å ããå¯èœæ§ã®ããæ»äº¡ããèæ ®ããŠããŸãã
çµæãšããŠãã¹ãŠã§ãŒãã³ã¯2020幎ãã2022幎ã«ãããŠãšãŒãããã®ä»åœã倧ããäžåãããã®çµæã¯ä»ã®å欧諞åœãšé©ãã»ã©äŒŒãŠããããšãåãããŸããã
ã42ã®ãšãŒããã諞åœã®ãã¡ã2020幎1æãã2022幎12æãŸã§ã®çޝç©è¶ éå šæ»æ»ã¯ãã«ã¯ã»ã³ãã«ã¯ã®äººå£10äžäººããã46人ãããã«ã¬ãªã¢ã®1,080äººã®æ»äº¡è ã®éã§ãäžå€®å€ã¯351/100,000人ã§ããããšåœŒãã¯æžããŠããŸãããã¹ãŠã§ãŒãã³ã§ã¯ãè¶ éæ»äº¡ç158/100,000ã¯æäœéšé¡ã«å ¥ãã42ãåœäž37äœããã«ãŠã§ãŒ(129人)ããã³ããŒã¯(97人)ããã£ã³ã©ã³ã(228人)ãšå€§ããå€ãããŸããã§ãããã
ã§ã¯ããªãã¹ãŠã§ãŒãã³ã¯2020幎ã«é£åœãšæ¯ã¹ãŠããã©ãŒãã³ã¹ãæ¯ãããªãã£ãã®ã§ãããã?ç ç©¶ã説æããããã«ãããã¯ã2019幎ã®äœæ»äº¡çã«ããæ»äº¡çã®ç§»åãããçµç¹åãããŠããªãé«éœ¢è ã±ã¢æ§é ãã«ãããã®ãšèããããŸãã
ããã¯ã©ãããæå³ã§ãããã?æ¬è³ªçã«ã2019幎ã®ã¹ãŠã§ãŒãã³ã§ã¯å šæ»å ã«ããæ»äº¡è æ°ãå€§å¹ ã«æžå°ãã2020幎ã«ã¯é節ãªã³ããã®åœ±é¿ãåããããæ¥µåºŠé«éœ¢è ãçåããŠããããšã«ãªããŸããããã¯ãã³ããé¢é£ã®æ»äº¡è æ°ã«ãã倧ããªå¹Žéœ¢å·®ã«ã衚ããŠããŸããã¹ãŠã§ãŒãã³ã§ã¯ããCOVID-19é¢é£æ»äº¡ã®~40%ãä»è·æœèšã®æ£è ãã§ãããå šã³ããæ»äº¡è ã®67%ã80æ³ä»¥äžã®å人ã§ããã®å¹Žéœ¢å±€ã®å šæ»äº¡è ã®10%ãå ããŠããããšç ç©¶ã¯è¿°ã¹ãŠããŸãã
è¥ãäžä»£ã«ãšã£ãŠã¯ãã³ããã¯ã»ãšãã©åé¡ã«ãªããŸããã§ãããã50æ³æªæºã®COVID-19æ»äº¡è ã¯å šCOVIDæ»äº¡è ã®ããã1.2%ã«éããããã®äžã«ã¯20æ³æªæºã®21人ãäž»ã«åºç€çŸæ£ãããããã®å¹Žéœ¢å±€ã®æ»äº¡è ã®1%ã«çžåœããŸããã
å®éãã³ããã¯éåžžã«é«éœ¢è ã襲ãã50æ³æªæºã®äººã ã¯ãã¹ã¯çŸ©åãããã¯ããŠã³ããªãã£ãã«ããããããã圱é¿ã¯éåžžã«éå®çã§ããã
ã¹ãŠã§ãŒãã³ã®ããã¯ããŠã³ã®æ¬ åŠã¯ããè¯ãçµæããããããŸãã
åæ§ã«éèŠãªã®ã¯ããšãŒãããååœã®ã峿 ŒåºŠææ°ããæ€èšŒãããã®å³æ Œããš2020幎ãã2022幎ã®éå°æ»äº¡çãæ¯èŒããããŒã¿è¡šãäœæããããšã§ããã€ãŸããåœã®æ¿çã¯ã©ãã»ã©å³æ Œã§ããããéå°ãªæ»äº¡çãæžããäžã§ã©ãã»ã©éèŠã ã£ãã®ã§ãããã?
å®ã¯ããã®ãã£ãŒããå®ç§ã«ç€ºããŠããæç¢ºã§å匷ãçããããããšãããããŸãããåœã¯å³æ Œæ§ææ°(x軞)ãšéå°æ»äº¡ç(y軞)ã«åºã¥ããŠãããããããŸãããã®ç·ã¯æ»äº¡çã®åŸåã瀺ããŠãããæ¿çã®å³ãããšéå°ãªæ»äº¡çã®é²æ¢ãšã®éã«ã¯ã»ãšãã©é¢ä¿ããããŸããã

峿 Œæ§ææ°ãšéå°æ»äº¡çã®é¢ä¿ã§ããRäºä¹ã¯ããã0.14ã§ãã1ã«è¿ãã»ã©ãçµæã«å¯Ÿããå³å¯ãããã匷ããªããŸããããã¯0.14ã§ãã
ã€ã¿ãªã¢ãã¹ãã€ã³ã®ãããªåœã ã¯ããã¯ããŠã³ã矩åä»ãã«é¢ããŠæãå³ããåœã®äžã€ã§ãããªãããéå°æ»äº¡çã§ã¯äžäœã«äœçœ®ããŠããŸãããã€ã®ãªã¹ããã«ãã¬ã«ããªã©ã³ããªã©ã¯ã¯ããã«å³ãããæããã«æªãçµæãåºããŠããŸããããã³ããŒã¯ã¯2çªç®ã«å³ãããªãåœã§ãããå°ãªããšããã®è©Šéšã§ã¯æè¯ã®çµæãåºããŸããã
ããã¯äœã瀺ããŠããã®ã§ãããã?ç°¡åã«èšãã°ããã¡ãŠãã¯ééã£ãŠãããã¹ãŠã§ãŒãã³ã¯é£åœãšæ¯ã¹ãŠå£æªãªæçžŸãåããŸããã§ããããšãŒãããã®ä»åœããããŠãã¡ããã¢ã¡ãªã«åè¡åœãããããªãè¯ãæçžŸãåããŸãããããã¯ããŠã³ã峿 Œãã¯éå°ãªæ»äº¡çã®æžå°ãšã¯å šãé¢ä¿ããããŸããã§ããã圌ãã¯ãã¹ã¯ççšã矩åä»ããããšã¯ãªããããã¯åœŒã®äž»èŠãªæ¿çæèšã®äžã€ã§ãããæ°ãæã«ãããN95ã¬ãã«ã®çŸ©åã課ããŠãããã€ãã®ãããªä»åœãããæçžŸãåããŸããã
ããã¯ããã¯ããŠã³ã¢ãã«ã®æç¢ºãªåŠå®ã§ããã ããããã仿¥ã¹ãŠã§ãŒãã³ã®äŸãæå³çã«ç¡èŠãããŠããã®ã§ãããªããªãããããã®æŽå²çã«æªè³ªãªæ¿çã®å®éã®çµæãç¥ãã«ã¯ãè¬èãã説æè²¬ä»»ãèª å®ããå¿ èŠã§ããããããã¯å€ãã®å ¬è¡è¡çåéã§æ¬åœã«æã¡åŸãªãè³è³ªã ããã§ãã